# Robert A. Hauser

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-a-hauser/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,459 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 93 |
| i10-index | 297 |
| Last Known Institution | University of South Florida |
| OpenAlex ID | https://openalex.org/A5080057970 |
| ORCID iD | https://orcid.org/0000-0002-6369-1203 |
| Works | 551 |

## Researcher papers

- [The Parkinson Progression Marker Initiative (PPMI)](https://scholariq.org/papers/the-parkinson-progression-marker-initiative-ppmi/)
- [A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease](https://scholariq.org/papers/a-randomized-clinical-trial-of-high-dosage-coenzyme-q10-in-early-parkinson/)
- [Practice Parameter: Therapies for essential tremor \[RETIRED\]](https://scholariq.org/papers/practice-parameter-therapies-for-essential-tremor-retired/)
- [Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease](https://scholariq.org/papers/effect-of-creatine-monohydrate-on-clinical-progression-in-patients-with/)
- [Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression](https://scholariq.org/papers/effect-of-urate-elevating-inosine-on-early-parkinson-disease-progression/)
- [Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls](https://scholariq.org/papers/longitudinal-csf-biomarkers-in-patients-with-early-parkinson-disease-and-healthy/)
- [Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study](https://scholariq.org/papers/clinical-and-dopamine-transporter-imaging-characteristics-of-non-manifest-lrrk2/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [University of South Florida](https://scholariq.org/institutions/university-of-south-florida/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.